GE医疗集团宣布扩大与生物医学高级研究与发展管理局（Barda）的合作协议，新增约3500万美元资金投入，重点开发用于创伤救治和应急准备的人工智能驱动超声技术。此次合作升级将加速智能超声系统的创新，通过AI算法提升紧急医疗场景下的诊断效率与准确性。项目旨在构建更敏捷的公共卫生应急响应体系，尤其在战场急救、灾害救援等高风险环境中实现快速伤情评估。新一代便携式超声设备将整合实时AI辅助分析功能，帮助医护人员在资源受限环境下做出关键临床决策。
GE医疗集团宣布扩大与生物医学高级研究与发展管理局（Barda）的合作协议，新增约3500万美元资金投入，重点开发用于创伤救治和应急准备的人工智能驱动超声技术。此次合作升级将加速智能超声系统的创新，通过AI算法提升紧急医疗场景下的诊断效率与准确性。项目旨在构建更敏捷的公共卫生应急响应体系，尤其在战场急救、灾害救援等高风险环境中实现快速伤情评估。新一代便携式超声设备将整合实时AI辅助分析功能，帮助医护人员在资源受限环境下做出关键临床决策。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.